AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

XORTX Therapeutics Inc.

CAD 3.19 -$16.81 (-84.05%)
TSXV · 31 Aug 2026 19:55 UTC
Previous Close
CAD 3.19
Day Range
CAD 3.19CAD 3.2
Year Range
CAD 2.42CAD 9.85
Market Cap
888.38K
AVG Volume
1.15K
Trailing/Forward PE
-0.32/0.79
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Toronto Stock Exchange VenturesCA
Net Income (USD)
-4M-3M-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-1.65M
26 Q1-795.22K
25 Q4-599.54K
25 Q3-642.27K
25 Q2-717.7K
25 Q1-698.67K
24 Q4122.53K
24 Q3-587.01K
24 Q2170.07K
24 Q1-3.02M
Operating Income (USD)
-4M-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-1.65M
26 Q1-809.8K
25 Q4-696.97K
25 Q3-708.26K
25 Q2-889.95K
25 Q1-963.46K
24 Q4-661.26K
24 Q3-874.75K
24 Q2-3.12M
24 Q1-1.09M
EBITDA (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-1.63M
26 Q1-784.38K
25 Q4-667.4K
25 Q3-613.21K
25 Q2-862.32K
25 Q1-937.47K
24 Q4-635.12K
24 Q3-848.8K
24 Q2-1.46M
24 Q1-1.06M
Cash Flows (USD)
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q20
26 Q1-505.15K
25 Q4-712.95K
25 Q3-620.87K
25 Q2-815.34K
25 Q1-647.12K
24 Q4-890.44K
24 Q3-775.03K
24 Q2-745.62K
24 Q1-1.31M
EPS (USD)
-40-30-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-1.02
26 Q1-0.57
25 Q4-2.37
25 Q3-3.25
25 Q2-4.75
25 Q1-4.75
24 Q40.93
24 Q3-5
24 Q21.75
24 Q1-31
Expenses (USD)
-4M-2M02MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2-1.54M
26 Q1161.3K
25 Q4691.93K
25 Q3684.68K
25 Q2674.4K
25 Q1757.49K
24 Q4418.83K
24 Q3604.55K
24 Q2912.02K
24 Q1588.41K
Cash & Debt (USD)
01M2M3M4MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2992.43K
26 Q1250.45K
25 Q4862.94K
25 Q31.66M
25 Q21.06M
25 Q11.9M
24 Q42.47M
24 Q32.3M
24 Q23.08M
24 Q13.84M
Debt ratios
00.20.40.60.824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Debt ratios by quarter
PeriodDebt ratios
26 Q20.27
26 Q10.08
25 Q40.27
25 Q30.52
25 Q20.3
25 Q10.48
24 Q40.61
24 Q30.52
24 Q20.62
24 Q10.75
Return on Capital
-150%-100%-50%0%50%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Return on Capital by quarter
PeriodReturn on Capital
26 Q2-29.97%
26 Q1-61.9%
25 Q4-28.81%
25 Q3-23.39%
25 Q2-35.34%
25 Q1-25.49%
24 Q43.67%
24 Q3-27.51%
24 Q26.29%
24 Q1-121.19%
Shares Outstanding
0500K1M1.5M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.62M
26 Q11.39M
25 Q4262.43K
25 Q3194.26K
25 Q2151.53K
25 Q1149.49K
24 Q4132.31K
24 Q3116.14K
24 Q2116.14K
24 Q197.17K
Book Value Per Share (USD)
010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q23.4
26 Q10.92
25 Q47.93
25 Q314.14
25 Q213.4
25 Q118.34
24 Q425.22
24 Q318.37
24 Q223.29
24 Q125.64
Total Assets (USD)
02M4M6M8M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q26.17M
26 Q12.15M
25 Q42.68M
25 Q33.92M
25 Q22.74M
25 Q13.5M
24 Q44.09M
24 Q33.85M
24 Q24.8M
24 Q16.05M
PE Ratio
22.533.54med 2.69Dec 22Jan 23Jan 23Feb 23Feb 23Mar 23Mar 23
XRTX.V PE Ratio by quarter
PeriodPE Ratio
Mar 232.14
Mar 232.23
Mar 232.4
Mar 232.73
Feb 232.56
Feb 232.69
Feb 232.69
Feb 232.66
Jan 232.69
Jan 233.32
Jan 233.61
Jan 233.22
Dec 223.68
Free Cash Flow Yield
-600%-400%-200%0%med -115.7%Dec 24Mar 25Jul 25Oct 25Feb 26May 26Sep 26
XRTX.V Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-83.03%
Aug 26-86.88%
Aug 26-92.05%
Aug 26-95.12%
Aug 26-94.87%
Jul 26-94.05%
Jul 26-91.06%
Jul 26-90.59%
Jul 26-93.66%
Jul 26-92.74%
Jun 26-515.95%
Jun 26-497.53%
Jun 26-465.75%
Jun 26-512.09%
May 26-464.88%
May 26-482.62%
May 26-413.7%
May 26-385.46%
May 26-383.97%
Apr 26-373.35%
Apr 26-487.81%
Apr 26-431.16%
Apr 26-98.86%
Mar 26-166.77%
Mar 26-131.25%
Mar 26-164.73%
Mar 26-138.38%
Feb 26-146.5%
Feb 26-164.17%
Feb 26-146.24%
Feb 26-144.32%
Jan 26-120.83%
Jan 26-108.92%
Jan 26-105.18%
Jan 26-106.47%
Jan 26-105.07%
Dec 25-103.34%
Dec 25-99.38%
Dec 25-99.19%
Dec 25-99.52%
Nov 25-100.64%
Nov 25-110.66%
Nov 25-148.39%
Nov 25-148.67%
Oct 25-128.45%
Oct 25-126.96%
Oct 25-77.16%
Oct 25-92.45%
Oct 25-104.67%
Sep 25-105.61%
Sep 25-101.53%
Sep 25-99.37%
Sep 25-105.72%
Aug 25-101.28%
Aug 25-99.2%
Aug 25-98.3%
Aug 25-100.49%
Aug 25-112.82%
Jul 25-112.09%
Jul 25-87.7%
Jul 25-86.81%
Jul 25-89.73%
Jun 25-119.16%
Jun 25-130.79%
Jun 25-124.06%
Jun 25-126.1%
May 25-122.51%
May 25-117.77%
May 25-108.99%
May 25-109.48%
May 25-112.48%
Apr 25-105.16%
Apr 25-120.51%
Apr 25-135.48%
Apr 25-124.9%
Mar 25-146.62%
Mar 25-137.14%
Mar 25-142.1%
Mar 25-144.02%
Feb 25-144.99%
Feb 25-168.69%
Feb 25-149.57%
Feb 25-162.74%
Jan 25-149.86%
Jan 25-157.07%
Jan 25-141.21%
Jan 25-110.97%
Jan 25-113.63%
Dec 24-131.09%
Dec 24-139.88%
Dec 24-128.67%
Dec 24-132.68%
Nov 24-113.21%
Nov 24-123.43%
Nov 24-110.38%
Nov 24-95.72%
Nov 24-108.18%
Oct 24-96.92%
Oct 24-78.39%
Oct 24-99.66%
EV/EBITDA
-202468med 1.77Apr 22May 22Jul 22Aug 22Sep 22Nov 22Dec 22
XRTX.V EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 22-0.53
Dec 220.66
Dec 221.65
Dec 222.75
Nov 222.75
Nov 221.06
Nov 222.55
Nov 221.16
Oct 221.16
Oct 221.56
Oct 221.26
Oct 223.74
Sep 226.72
Sep 221.77
Sep 222.05
Sep 222.21
Sep 222.53
Aug 222.77
Aug 223.21
Aug 222.89
Aug 222.69
Jul 222.09
Jul 222.61
Jul 224.21
Jul 221.61
Jun 222.17
Jun 220.27
Jun 220.29
Jun 220.87
Jun 220.16
May 220.45
May 220.32
May 220.98
May 221.72
Apr 220.27
Apr 221.77
Apr 221.94
Apr 222.06
Apr 221.92
Price to Book
0123med 1.1Dec 24Mar 25Jul 25Oct 25Feb 26May 26Sep 26
XRTX.V Price to Book by quarter
PeriodPrice to Book
Sep 262.49
Aug 262.38
Aug 262.24
Aug 262.17
Aug 262.18
Jul 262.2
Jul 262.27
Jul 262.28
Jul 262.21
Jul 262.23
Jun 260.26
Jun 260.27
Jun 260.29
Jun 260.26
May 260.29
May 260.28
May 260.32
May 260.35
May 260.35
Apr 260.36
Apr 260.28
Apr 260.31
Apr 261.36
Mar 260.65
Mar 260.83
Mar 260.66
Mar 260.78
Feb 260.74
Feb 260.66
Feb 260.74
Feb 260.75
Jan 260.9
Jan 260.99
Jan 261.03
Jan 261.02
Jan 261.03
Dec 251.05
Dec 251.09
Dec 251.09
Dec 251.09
Nov 251.08
Nov 250.98
Nov 251.04
Nov 251.04
Oct 251.2
Oct 251.21
Oct 252
Oct 251.67
Oct 251.47
Sep 251.06
Sep 251.1
Sep 251.12
Sep 251.06
Aug 251.1
Aug 251.12
Aug 251.13
Aug 251.11
Aug 250.99
Jul 251
Jul 251.27
Jul 251.29
Jul 251.24
Jun 250.94
Jun 250.85
Jun 250.9
Jun 250.88
May 250.91
May 250.95
May 251.02
May 251.02
May 250.99
Apr 251.06
Apr 250.92
Apr 250.82
Apr 250.89
Mar 251.32
Mar 251.41
Mar 251.36
Mar 251.35
Feb 251.34
Feb 251.15
Feb 251.3
Feb 251.19
Jan 251.29
Jan 251.23
Jan 251.37
Jan 251.75
Jan 251.71
Dec 241.25
Dec 241.17
Dec 241.28
Dec 241.24
Nov 241.45
Nov 241.33
Nov 241.49
Nov 241.71
Nov 241.52
Oct 241.69
Oct 242.09
Oct 241.65
XORTX Therapeutics Inc.
XRTX.V
Stockpicker

Video analysis: XRTX.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.